Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer
Gastric Cancer Dec 13, 2018
Furukawa K, et al. - Researchers studied the effect of preoperative wait time on survival in cases with clinical stage (cStage) II/III gastric cancer in 467 male (67%) and 229 female (33%) subjects, with a median patient age of 67 years, from 2002 to 2012. Preoperative wait time was described as the time from endoscopy for initial diagnosis to surgery. They divided cases into 3 groups viz, short wait group (≤ 30 days), intermediate wait group (> 30 and ≤ 60 days), and long wait group (> 60 and ≤ 90 days). The body mass index was observed lower in the short wait group. No prognosis was related to wait time as preoperative wait time up to 90 days did not influence survival in cStage II/III gastric cancer cases.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries